Rheumatological diseases and cancer: The hidden variable of radiation exposure

Annals of the Rheumatic Diseases

Volumn 73, Issue 12, 2014, Pages 2065-2068

  Picano, Eugenio ^a   Semelka, Richard ^b   Ravenel, James ^c   Matucci Cerinic, Marco ^d  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT;

BRAIN CANCER; CANCER RISK; CHROMOSOME DAMAGE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DNA DAMAGE; EDITORIAL; GENOTOXICITY; HUMAN; INTERSTITIAL LUNG DISEASE; IONIZING RADIATION; LEUKEMIA; LUNG FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION INDUCED NEOPLASM; RADIATION PROTECTION; RHEUMATIC DISEASE; SYSTEMIC SCLEROSIS; FEMALE; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROCEDURES; RADIOGRAPHY;

FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; SCLERODERMA, SYSTEMIC;

EID: 84922246508     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206585     Document Type: Editorial

References (41)

1. Onishi A, Sugiyama D, Kumagai S, et al. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 2013;65:1913-21.
2. Bonifazi M, Tramacere I, Pomponio G, et al. Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 2013;52:143-54.
3. Zhang JQ, Wan YN, Peng WJ, et al. The risk of cancer development in systemic sclerosis: A meta-analysis. Cancer Epidemiol 2013;37:523-7.
4. Bernatsky S, Ramsey-Goldman R, Labrecque J, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun 2013;42:130-5.
5. Mercer LK, Davies R, Galloway JB, et al. British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium. Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology (Oxford) 2013;52:91-8.
6. Pouplard C, Brenaut E, Horreau C, et al. Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol 2013;27:36-46.
7. Turesson C, Matteson EL. Malignancy as a comorbidity in rheumatic diseases. Rheumatology (Oxford) 2013;52:5-14.
8. Frauenfelder T, Winklehner A, Nguyen TDN, et al. Screening for interstitial lung disease in systemic sclerosis: performance of high resolution computed tomography with limited number of slices - a prospective study. Ann Rheum Dis 2014;73:2069-73.
9. Mettler FA Jr, Bhargavan M, Faulkner K, et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources - 1950-2007. Radiology 2009;253:520-31.
10. Mettler FA Jr, Huda W, Yoshizumi TT, et al. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008;248:254-63.
11. Health Risks from Exposure to Low Levels of Ionizing Radiation. BEIR VII Phase 2. Committee to assess health risks from exposure to low levels of ionizing radiation. The National Academies Press, 2008. http://www.nap.edu
12. Picano E, Matucci-Cerinic M. Unnecessary radiation exposure from medical imaging in the rheumatology patient. Rheumatology (Oxford) 2011;50:1537-9.
13. Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012;380:499-505.
14. Mathews JD, Forsythe AV, Brady Z, et al. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 2013;346:f2360.
15. Eisenberg MJ, Afilalo J, Lawler PR, et al. Cancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarction. CMAJ 2011;183:430-6.
16. ICRP Publication 103. The 2007 Recommendations of the International Commission on Radiological Protection. http://www.icrp.org/docs/ICRP-Publication-103-Annals-of-the-ICRP-37(2-4)-Free-extract.pdf
17. Avouac J, Huscher D, Furst DE, et al. for the EPOSS group. Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis. Ann Rheum Dis 2014;73:191-7.
18. Strollo D, Goldin J. Imaging lung disease in systemic sclerosis. Curr Rheumatol Rep 2010;12:156-61.
19. Baron M, Feiglin D, Hyland R, et al. 67-Gallium lung scans in progressive systemic sclerosis. Arthritis Rheum 1983;26:969-74.
20. Ishida R, Murata Y, Sawada Y, et al. Thallium-201 myocardial SPET in patients with collagen disease. Nucl Med Commun 2000;21:729-34.
21. Wessberg P, Danielson BI, Willén J. Comparison of Cobb angles in idiopathic scoliosis on standing radiographs and supine axially loaded MRI. Spine 2006;31:3039-44.
22. Pijpe A, Andrieu N, Easton DF, et al. GENEPSO; EMBRACE; HEBON. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ 2012;345:e5660.
23. McCurdy D, Tai LQ, Frias S, et al. Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis. Radiat Res 1997;147:48-54.
24. Abu-Shakra M, Lee P. Exaggerated fibrosis in patients with systemic sclerosis (scleroderma) following radiation therapy. J Rheumatol 1993;20:1601-3.
25. Yarnold J, Brotons MC. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol 2010;97:149-61.
26. Radis CD, Kahl LE, Baker GL, et al. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year follow-up study. Arthritis Rheum 1995;38:1120-7.
27. Dobrzyńska MM. The effects in mice of combined treatments to X-rays and antineoplastic drugs in the Comet assay. Toxicology 2005;207:331-8.
28. ICRP Statement on Tissue Reactions / Early and Late Effects of Radiation in Normal Tissues and Organs - Threshold Doses for Tissue Reactions in a Radiation Protection Context. ICRP Publication 118 Ann. ICRP 41. 2012. http://www. icrp.org/publication.asp?id=ICRP%20Publication%20118
29. Brunborg G, Holme JA, Hongslo JK. Inhibitory effects of paracetamol on DNA repair in mammalian cells. Mutat Res 1995;342:57-170.
30. Winklehner A, et al. Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices. Ann Rheum Dis 2012;71:549-52.
31. Gargani L, Pignone A, Agoston G, et al.: Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study. Am Heart J 2013;165:200-7.
32. Picano E, Pellikka PA. Stress echo applications beyond coronary artery disease. Eur Heart J 2014;35:1033-40.
33. Smith-Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA 2012;307:2400-9.
34. Picano E. Stress echocardiography: a historical perspective. Am J Med 2003;114:126-30.
35. Sicari R, Nihoyannopoulos P, Evangelista A, et al. European Association of Echocardiography. Stress Echocardiography Expert Consensus Statement - Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 2009;30:278-89.
36. Link TM. Osteoporosis imaging: state of the art and advanced imaging. Radiology 2012;263:3-17.
37. Gargani L, Doveri M, D'Errico L, et al. Ultrasound lung comets in systemic sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosis. Rheumatology (Oxford) 2009;48:1382-7.
38. Barskova T, Gargani L, Guiducci S, et al. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. Ann Rheum Dis 2013;72:390-5.
39. Picano E, Vañó E, Rehani MM, et al. The appropriate and justified use of medical radiation in cardiovascular imaging. A position document of the ESC associations of cardiovascular imaging, percutaneous cardiovascular interventions and electrophysiology. Eur Heart J 2014;35:665-72.
40. U.S. Food and Drug Administration. Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging. February 2010. http://www.fda. gov/downloads/Radiation-EmittingProducts/RadiationSafety/RadiationDoseReduction/UCM200087.pdf
41. Andreassi MG, Picano E. Reduction of radiation to children. Our responsibility to change. Editorial comment. Circulation 2014;130:135-7.